Baxter Faces Securities Class Actions Over Novum IQ Pump as Firms Seek Lead Plaintiff
Investors face a December 15 deadline to seek lead-plaintiff status in the Illinois federal case.
Overview
- The case is pending in the U.S. District Court for the Northern District of Illinois as Electrical Workers Pension Fund, Local 103, I.B.E.W. v. Baxter International Inc., No. 1:25-cv-12672.
- Complaints allege the Novum IQ Large Volume Pump had systemic defects causing underinfusion, overinfusion, and non-delivery that were linked to reported injuries and deaths.
- Plaintiffs assert Baxter’s customer alerts failed to remedy persistent design problems and that statements about safety, rollout, and sales prospects were misleading.
- On July 31, 2025, Baxter announced a voluntary pause of Novum IQ LVP shipments and installations with no restart date, and the stock fell more than 22% that day, according to the filings.
- Multiple firms, including Bleichmar Fonti & Auld, Robbins Geller, Portnoy, Levi & Korsinsky, Lowey Dannenberg, Bragar Eagel & Squire, and Faruqi & Faruqi, are inviting investors from the February 23, 2022 to July 30, 2025 class period to move for lead-plaintiff status by December 15.